Document Classification

Section Type: RESULTS

Text: Compared with subjects receiving placebo, participants who received sibutramine had a significantly greater reduction in weekly binge frequency (sibutramine group mean = 2. 7 [SD = 1. 7], placebo group mean = 2. 0 [SD = 2. 3]) ; weight loss (sibutramine group mean = 4. 3 kg [SD = 4. 8], placebo group mean = 0. 8 kg [SD = 3. 5]) ; reduction in frequency of binge days ; reduction in body mass index ; global improvement ; level of response, including the percentage of abstinence from binge eating (sibutramine group : 58. 7 % ; placebo group : 42. 8 %) ; and reduction in eating pathology (cognitive restraint, disinhibition, and hunger).